Pre/perimenopausal (preMeno) women receiving palbociclib (PAL) for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2‒) advanced breast cancer (ABC) in a real-world setting: Treatment patterns from POLARIS
Files
Link to Full Text
Download Full Text
Publication Date
12-2020
Disciplines
Oncology
Area of Special Interest
Cancer
Area of Special Interest
Women & Children
Specialty/Research Institute
Oncology
Conference / Event Name
San Antonio Breast Cancer Symposium
Location
Virtual Symposium
